Publications dans lesquelles il/elle collabore avec Enrique Lerma Puertas (19)

2017

  1. CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma

    Virchows Archiv, Vol. 470, Núm. 1, pp. 81-90

2016

  1. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs

    Experimental and Molecular Pathology, Vol. 100, Núm. 3, pp. 460-468

2015

  1. FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma

    Breast Cancer Research and Treatment, Vol. 153, Núm. 2, pp. 465-474

  2. Osteopontin regulates VEGFA and ICAM-1 mRNA expression in breast carcinoma

    American Journal of Clinical Pathology

2014

  1. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence

    Human Pathology

  2. Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma

    British Journal of Cancer, Vol. 111, Núm. 4, pp. 689-695

2012

  1. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas

    Journal of Cancer, Vol. 3, Núm. 1, pp. 175-183

  2. Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas

    Human Pathology, Vol. 43, Núm. 11, pp. 1902-1909

  3. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

    British Journal of Cancer, Vol. 106, Núm. 8, pp. 1367-1373

2011

  1. Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma

    Modern Pathology, Vol. 24, Núm. 2, pp. 201-208

  2. Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas

    Human Pathology, Vol. 42, Núm. 11, pp. 1581-1588

  3. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: A cooperative effort?

    Human Pathology, Vol. 42, Núm. 1, pp. 103-110

2009

  1. Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma

    Breast Cancer Research and Treatment, Vol. 117, Núm. 2, pp. 433-441

2008

  1. Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

    Virchows Archiv, Vol. 453, Núm. 2, pp. 133-139

  2. Reply to Rakha, Ellis and Reis-Filho

    Modern Pathology

2007

  1. Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)

    Modern Pathology, Vol. 20, Núm. 11, pp. 1200-1207

2001

  1. Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

    Breast, Vol. 10, Núm. 1, pp. 67-77

1997

  1. Prognostic value of S-Phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis

    Modern Pathology, Vol. 10, Núm. 3, pp. 216-222

1994

  1. Detection of steroid receptors in breast cancer: Relationship between EIA and IHC methods

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 54, Núm. 8, pp. 591-594